Document Detail

Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis.
MedLine Citation:
PMID:  21496826     Owner:  NLM     Status:  Publisher    
OBJECTIVE: Spirometry is the most common test recommended to monitor respiratory dysfunction in patients of amyotrophic lateral sclerosis (ALS). However, the test depends on the patient's efforts and may be difficult to conduct in patients with faciobulbar weakness. We aimed to study the role of phrenic nerve-electrophysiological studies to predict respiratory dysfunction and correlate it with the forced vital capacity (FVC) in patients of ALS. METHODS: Forty-three unselected patients (32 male, 25 with limb-onset ALS, age 50±15years) with clinically definite or probable ALS were included. They were evaluated at entry and after a period of 6months with the ALS functional rating scale (ALSFRS), their respiratory subscores (ALS-FRSr), their FVC values as determined by spirometry, and phrenic nerve studies. RESULTS: Six patients could not perform a satisfactory spirometry at the onset and during the course of illness. All the six patients had severe faciobulbar weakness. Respiratory abnormalities on spirometry were found in 85% of patients, whereas only 30% were symptomatic for respiratory dysfunction. In patients with severe respiratory dysfunction (FVC<60%), the phrenic nerve motor amplitudes (PNAMPs) were significantly reduced compared to those with mild-to-moderate respiratory dysfunction (FVC≥60%). The FVC value showed a significant correlation with the PN-AMP. Nine patients had a poor outcome (death or severe disability) at the end of a period of 6months. Low levels of both FVC and PN-AMP were predictors of poor outcome for patients at the end of 6months. CONCLUSION: We conclude that respiratory dysfunction, as determined by spirometry, is common in patients of ALS. However, only about one-third of patients show symptoms of respiratory distress. Clinical symptoms of respiratory distress are unreliable predictors of respiratory failure in ALS. Measurement of PN-AMP at the time of presentation may be an additional tool to assess respiratory dysfunction in ALS. Reduced PN-AMP values may be indicative of low FVC and may have some role in the assessment of respiratory function in patients in whom a routine spirometry is not possible due to limitations arising from the illness. Both low FVC and reduced PN-AMP at the time of presentation are predictors of poor outcome for patients at the end of 6months.
Dilip Singh; Rajesh Verma; Ravindra Kumar Garg; Maneesh Kumar Singh; Rakesh Shukla; S K Verma
Related Documents :
25318446 - A comprehensive clinical and genetic study of a large mexican population with spinocere...
11773816 - Bispectral index (bis) may not predict awareness reaction to intubation in surgical pat...
6688006 - Atracurium in clinical anaesthesia.
7895386 - Nasopharyngeal carcinoma and middle ear effusion: natural history and the effect of ven...
3129236 - Capnography in mechanically ventilated patients.
8804486 - Is intravenous urography indicated in a young adult with hematuria?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-13
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  -     ISSN:  1878-5883     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier B.V. All rights reserved.
Department of Neurology, Chhatrapati Shahuji Maharaj Medical University Uttar Pradesh, Lucknow, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ultra-thin-layer chromatography mass spectrometry and thin-layer chromatography mass spectrometry of...
Next Document:  A novel codon4 mutation (A4F) in the SOD1gene in familial amyotrophic lateral sclerosis.